Screener
Exascale Labs Holdings Inc. XLAB Ratios & Valuation
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 16.3%+0.6pp | 16.2%— | 16.1%— | 16%— | 15.8%— | |
| Operating margin | -32.4%+11.0pp | -33.9%— | -35.9%— | -38.9%— | -43.4%— | |
| Net margin | -82.1%+27.1pp | -85.7%— | -90.8%— | -98%— | -109.2%— | |
| Valuation | ||||||
| Market capitalization | $94.57M-64.2% | $163.06M— | —— | —— | —— | |
| Price / sales | 6.4×— | 12.7×— | —— | —— | —— |
FAQ
- What are Exascale Labs Holdings Inc.'s profit margins?
- Exascale Labs Holdings Inc. (XLAB) runs a 16.3% gross margin and a -32.4% operating margin, with a -82.1% net margin.
- Where do Exascale Labs Holdings Inc.'s ratios come from?
- Every ratio is computed from Exascale Labs Holdings Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
